These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 33316266)

  • 21. Post-COVID pulmonary fibrosis: therapeutic efficacy using with mesenchymal stem cells - How the lung heals.
    Vishnupriya M; Naveenkumar M; Manjima K; Sooryasree NV; Saranya T; Ramya S; Harysh Winster S; Paulpandi M; Balachandar V; Arul N
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2748-2751. PubMed ID: 33829461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.
    Sanguedolce F; Zanelli M; Froio E; Bisagni A; Zizzo M; Ascani S; Stallone G; Netti S; Ranieri E; Falagario U; Carrieri G; Cormio L
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):563-575. PubMed ID: 34236278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein.
    Zhang ZY; Ju CY; Wu LZ; Yan H; Hong WB; Chen HZ; Yang PB; Wang BR; Gou T; Chen XY; Jiang ZH; Wang WJ; Lin T; Li FN; Wu Q
    Cell Chem Biol; 2023 Mar; 30(3):261-277.e8. PubMed ID: 36889311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.
    Edler C; Schröder AS; Aepfelbacher M; Fitzek A; Heinemann A; Heinrich F; Klein A; Langenwalder F; Lütgehetmann M; Meißner K; Püschel K; Schädler J; Steurer S; Mushumba H; Sperhake JP
    Int J Legal Med; 2020 Jul; 134(4):1275-1284. PubMed ID: 32500199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?
    Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Richeldi L; Corsico AG
    Cells; 2021 May; 10(5):. PubMed ID: 34068958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β.
    Colarusso C; Terlizzi M; Maglio A; Molino A; Candia C; Vitale C; Hansbro PM; Vatrella A; Pinto A; Sorrentino R
    Front Immunol; 2022; 13():934264. PubMed ID: 35844548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Discovery of intervention effect of Chinese herbal formulas on COVID-19 pulmonary fibrosis treated by VEGFR and FGFR inhibitors].
    Bian YQ; Ma J; Ren Y; Zhang YL; Qiao YJ
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1481-1487. PubMed ID: 32489024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.
    Rumende CM
    Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes.
    Schwartz DA
    Arch Pathol Lab Med; 2020 Jul; 144(7):799-805. PubMed ID: 32180426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus infection induced pulmonary fibrosis.
    Huang WJ; Tang XX
    J Transl Med; 2021 Dec; 19(1):496. PubMed ID: 34876129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection.
    Lechowicz K; Drożdżal S; Machaj F; Rosik J; Szostak B; Zegan-Barańska M; Biernawska J; Dabrowski W; Rotter I; Kotfis K
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9.
    Oatis D; Simon-Repolski E; Balta C; Mihu A; Pieretti G; Alfano R; Peluso L; Trotta MC; D'Amico M; Hermenean A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
    Zheng Z; Peng F; Zhou Y
    Chin Med J Pulm Crit Care Med; 2023 Jun; 1(2):77-83. PubMed ID: 37388822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential mechanisms for lung fibrosis associated with COVID-19 infection.
    Parimon T; Espindola M; Marchevsky A; Rampolla R; Chen P; Hogaboam CM
    QJM; 2023 Jul; 116(7):487-492. PubMed ID: 36018274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection.
    Mylvaganam RJ; Bailey JI; Sznajder JI; Sala MA;
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID-19.
    Razzaq A; Disoma C; Zhou Y; Tao S; Chen Z; Liu S; Zheng R; Zhang Y; Liao Y; Chen X; Liu S; Dong Z; Xu L; Deng X; Li S; Xia Z
    Rev Med Virol; 2024 Jan; 34(1):e2500. PubMed ID: 38126937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.